miR-124-3p derived from plasma exosomes enhances M2 macrophage polarization to treat acute lung injury
The Journal of Immunology · 01.09.2025 · 214 (9) · 2281-2297
DOI: 10.1093/jimmun/vkaf097 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 07.07.2025. Verfasst von Jing Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, South China Hospital Affiliated to Shenzhen University, Shenzhen, China. Hauptthemen laut MEDLINE: Acute Lung Injury, MicroRNAs, Exosomes, Macrophages. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation Science and Health, Major Project of Jiangxi Provincial Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute lung injury (ALI) post–lung transplantation (LT) is a major clinical challenge. This study investigates the role of exosomal miR-124-3p in modulating macrophage polarization and ameliorating ALI. Using male C57BL/6J mice, we established a left lung orthotopic transplantation model. Transcriptomic analysis revealed that miR-124-3p was significantly downregulated in the plasma exosomes of LT mice. Functional experiments demonstrated that plasma exosomal miR-124-3p promotes M2 macrophage polarization by targeting Krüppel-like factor 6 (KLF6) and inhibiting the NF-κB pathway. Overexpression of miR-124-3p significantly reduced inflammation, enhanced lung tissue repair, and improved oxygenation indices in vivo. In vitro, exosomal miR-124-3p reduced M1 markers (iNOS, IL-1β, IL-6) and increased M2 markers (Arg1, Ym1, Fizz1) in macrophages, confirmed by flow cytometry and Western blot. Furthermore, overexpression of KLF6 reversed the therapeutic effects of miR-124-3p. This study identifies miR-124-3p as a critical regulator of macrophage polarization and ALI pathophysiology, providing a potential therapeutic target for managing ALI in lung transplant recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, South China Hospital Affiliated to Shenzhen University, Shenzhen, China.
- Department of Respiratory and Critical Care Medicine, HeYou Hospital, Foshan, China.
- Department II of Respiratory and Critical Care in Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
ORCID-Profile: Jing Yang
Förderung
- Hunan Provincial Natural Science Foundation Science and Health
- Major Project of Jiangxi Provincial Health Commission
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation Science and Health Joint Program
Zitieren
APA
Yang, J., Yin, X., & Zhang, T. (2025). miR-124-3p derived from plasma exosomes enhances M2 macrophage polarization to treat acute lung injury. The Journal of Immunology, 214(9), 2281-2297. https://doi.org/10.1093/jimmun/vkaf097
Vancouver
Yang J, Yin X, Zhang T. miR-124-3p derived from plasma exosomes enhances M2 macrophage polarization to treat acute lung injury. The Journal of Immunology. 2025;214(9):2281-2297. doi:10.1093/jimmun/vkaf097
BibTeX
@article{Yang2025,
author = {Yang, Jing and Yin, Xiaokang and Zhang, Ting},
title = {miR-124-3p derived from plasma exosomes enhances M2 macrophage polarization to treat acute lung injury},
journal = {The Journal of Immunology},
year = {2025},
volume = {214},
number = {9},
pages = {2281--2297},
doi = {10.1093/jimmun/vkaf097}
}
EUVIMED